What are the door-to-treatment goals for STEMI and high-risk non-STEMI ACS?

Updated: Sep 15, 2020
  • Author: Catharine A Bon, MD; Chief Editor: Kirsten A Bechtel, MD  more...
  • Print


For STEMI and high-risk non-STEMI ACS, adjunctive therapies should begin as indicated. For STEMI with symptom onset 12 or fewer hours ago, reperfusion should not be delayed. Selection of therapy is defined by patient and center criteria, with the following door-to-treatment goals:

  • Percutaneous coronary intervention (PCI): 90 minutes

  • Fibrinolysis: 30 minutes

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!